From January 1, 2024 to March 31, 2024, the company has repurchased 10,300,000 shares, representing 0.5% for $1,000 million. With this, the company has completed the repurchase of 53,857,720 shares, representing 2.6% for $5,355.51 million under the buyback announced on July 18, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
90.54 CHF | +0.85% | +1.67% | +6.68% |
May. 06 | NOVARTIS AG : UBS maintains a Buy rating | ZD |
May. 02 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.68% | 203B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.70% | 238B | |
-9.08% | 198B | |
+6.70% | 165B | |
-1.81% | 160B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Tranche Update on Novartis AG's Equity Buyback Plan announced on July 18, 2023.